6533b7d1fe1ef96bd125c306
RESEARCH PRODUCT
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary
Alfredo BerrutiVittorio FuscoGaetano LanzettaGianmauro NumicoGiuseppina CampisiFrancesco BertoldoAlfredo AddeoToni IbrahimAlberto BedogniGiordana BettiniGiorgia SaiaOscar BertettoDaniele Santinisubject
medicine.medical_specialtyBisphosphonate-associated osteonecrosis of the jawOncology (nursing)business.industryHealth PolicyMEDLINEGuidelinemedicine.diseaseClinical PracticeOncologymascc isoo ascoo mrojHumansMedicineBisphosphonate-Associated Osteonecrosis of the JawbusinessOsteonecrosis of the jawIntensive care medicineyear | journal | country | edition | language |
---|---|---|---|---|
2020-03-01 | JCO Oncology Practice |